| Overview of the European and North American studies on HPV testing in primary cervical cancer screening J Cuzick, C Clavel, KU Petry, CJLM Meijer, H Hoyer, S Ratnam, ... International journal of cancer 119 (5), 1095-1101, 2006 | 1476 | 2006 |
| Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study J Dillner, M Rebolj, P Birembaut, KU Petry, A Szarewski, C Munk, ... Bmj 337, 2008 | 795 | 2008 |
| Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence SK Kjær, K Frederiksen, C Munk, T Iftner Journal of the National Cancer Institute 102 (19), 1478-1488, 2010 | 722 | 2010 |
| Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients KU Petry, S Menton, M Menton, F van Loenen-Frosch, ... British journal of cancer 88 (10), 1570-1577, 2003 | 551 | 2003 |
| TLR9 expression and function is abolished by the cervical cancer-associated human papillomavirus type 16 UA Hasan, E Bates, F Takeshita, A Biliato, R Accardi, V Bouvard, ... The Journal of Immunology 178 (5), 3186-3197, 2007 | 453 | 2007 |
| Chapter 12: Human papillomavirus technologies T Iftner, LL Villa Jnci Monographs 2003 (31), 80-88, 2003 | 330 | 2003 |
| The absolute risk of cervical abnormalities in high-risk human papillomavirus–positive, cytologically normal women over a 10-year period S Kjaer, E Høgdall, K Frederiksen, C Munk, A van den Brule, E Svare, ... Cancer research 66 (21), 10630-10636, 2006 | 300 | 2006 |
| The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors A Iftner, SJ Klug, C Garbe, A Blum, A Stancu, SP Wilczynski, T Iftner Cancer research 63 (21), 7515-7519, 2003 | 265 | 2003 |
| Population‐based prevalence, type‐and age‐specific distribution of HPV in women before introduction of an HPV‐vaccination program in Denmark SK Kjær, G Breugelmans, C Munk, J Junge, M Watson, T Iftner International Journal of Cancer 123 (8), 1864-1870, 2008 | 235 | 2008 |
| Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high … K Grassmann, B Rapp, H Maschek, KU Petry, T Iftner Journal of virology 70 (4), 2339-2349, 1996 | 234 | 1996 |
| Cutaneous Human Papillomaviruses Found in Sun-Exposed Skin: Beta-papillomavirus Species 2 Predominates in Squamous Cell Carcinoma O Forslund, T Iftner, K Andersson, B Lindelöf, E Hradil, P Nordin, ... Journal of Infectious Diseases 196 (6), 876-883, 2007 | 224 | 2007 |
| Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2 J Wu, C Lee, D Yokom, H Jiang, MCU Cheang, E Yorida, D Turbin, ... Cancer research 66 (9), 4872-4879, 2006 | 209 | 2006 |
| Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1 T Iftner, M Elbel, B Schopp, T Hiller, JI Loizou, KW Caldecott, ... The EMBO journal 21 (17), 4741-4748, 2002 | 201 | 2002 |
| Comparison of the properties of the E6 and E7 genes of low-and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 … A Schmitt, JB Harry, B Rapp, FO Wettstein, T Iftner Journal of virology 68 (11), 7051-7059, 1994 | 191 | 1994 |
| Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study X Castellsagué, T Iftner, E Roura, JA Vidart, SK Kjaer, FX Bosch, N Muñoz, ... Journal of medical virology 84 (6), 947-956, 2012 | 183 | 2012 |
| The E8^ E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes F Stubenrauch, M Hummel, T Iftner, LA Laimins Journal of virology 74 (3), 1178-1186, 2000 | 177 | 2000 |
| Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up KE Jensen, S Schmiedel, B Norrild, K Frederiksen, T Iftner, SK Kjaer British journal of cancer 108 (1), 234-239, 2013 | 175 | 2013 |
| High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression J Reiser, J Hurst, M Voges, P Krauss, P Münch, T Iftner, F Stubenrauch Journal of virology 85 (21), 11372-11380, 2011 | 170 | 2011 |
| Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 B Krämer, R Knoll, L Bonaguro, M ToVinh, J Raabe, ... Immunity 54 (11), 2650-2669. e14, 2021 | 169 | 2021 |
| Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women A Nielsen, SK Kjaer, C Munk, T Iftner Sexually transmitted diseases 35 (3), 276-282, 2008 | 166 | 2008 |
